JP Morgan Put 165 PGR 15.11.2024/ DE000JT30UD5 /
10/16/2024 11:54:09 AM | Chg.-0.003 | Bid3:32:53 PM | Ask3:32:53 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.008EUR | -27.27% | 0.008 Bid Size: 1,000 |
0.310 Ask Size: 1,000 |
Progressive Corporat... | 165.00 USD | 11/15/2024 | Put |
Newsfile Corp
10/13
SEE Shines at New York Climate Week, Highlighting Progressive Climate Solutions In China
GlobeNewswire
9/2
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire
8/30
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Paten...
GlobeNewswire
8/30
Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA App...
GlobeNewswire
8/29
The Alignment Studio Announces Launch of Women’s Health Physiotherapy Services in Melbourne
GlobeNewswire
8/28
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodege...
GlobeNewswire
8/26
Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treat...
GlobeNewswire
8/22
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire
8/21
CPAClub™ and Caseware™ Partner to Elevate Audit Quality for Progressive Accounting Firms
GlobeNewswire
8/19
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire
8/19
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire
8/15
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire
8/14
Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire
8/14
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire
8/13
Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire
8/12
Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update